Viedoc Technologies
263 reviews
- 1 profiles
- 3 categories
Average star rating
4.5
Serving customers since
2003
Viedoc Technologies Reviews
UR
Verified User in Research
Easy Form Creation, Fast Changes, and Responsive Support
The platform is intuitive and makes it easy to build forms and implement changes efficiently. Also when I run into difficulties, the customer support is responsive and helpful, often providing alternative solutions when my build is not feasible.
MA
Marina A.
Simple, Versatile Design and a Product That Keeps Up With a Fast-Moving Market
The design is simple and versatile—it can adapt to pretty much any study. Viedoc seems to have all users in mind: Designer, DM, PM, CRA, sites, and more. I also really appreciate the implementation of new features; Viedoc is keeping up with a fast-moving market.
AM
Verified User in Medical Devices
User-Friendly Design with Room for Improvement
I find Viedoc very user-friendly with its easy and fast drag-and-drop option. The flexibility it offers during design is something I really appreciate, especially with the drag-and-drop feature. It saves me a lot of time during my designs. The initial setup was easy and interesting.
About
What is Viedoc Technologies?
Viedoc Technologies is a software company that specializes in providing cloud-based solutions for clinical trial management. Their platform offers tools for data collection, trial monitoring, and patient engagement, designed to enhance the efficiency and quality of clinical research. With a focus on user-friendly interfaces and flexible integration options, Viedoc aims to streamline the clinical trial process for sponsors, CROs, and sites. For more information, visit their website at [viedoc.com](https://www.viedoc.com/).
Details
Year Founded
2003
Website
www.viedoc.comHunting for software insights?
With over 3 million reviews, we can provide the specific details that help you make an informed software buying decision for your business. Finding the right product is important, let us help.
or continue with
or continue with
By proceeding, you agree to our Terms of Use and Privacy Policy